Effects of an ICT-platform for Assessment and Management of Patient-reported Symptoms During Treatment for Breast Cancer
The purpose of this study is to evaluate the effects of an interactive Information and Communication Technologies (ICT) -platform for use in a smartphone or tablet in patients treated with neoadjuvant chemotherapy for breast cancer. The hypothesis is that clinical management will be improved and costs reduced and safe and participatory care promoted, when patients report symptoms in an application which provides self-care advice and instant access to professionals.
Breast Cancer
DEVICE: Smartphone or tablet
Questionnaire Scale for Functional Health Literacy (S-FHL-Swedish version), To evaluate self-reported data in terms of understanding health, Up to 3 months after completion of neoadjuvant chemotherapy treatment|Questionnaire Scale for Communicative and Critical Health Literacy (S-C & C HL - Swedish version), To evaluate self-reported data in terms of communicating health, Up to 3 months after completion of neoadjuvant chemotherapy treatment|Questionnaire Individualized Care Scale (ICS), To evaluate self-reported data in terms of individualized care, Up to 3 months after completion of neoadjuvant chemotherapy treatment|Questionnaire Sense of Coherence Scale (KASAM), To evaluate self-reported data in terms of Sense of Coherence, Up to 3 months after completion of neoadjuvant chemotherapy treatment|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30), To evaluate self-reported data in terms of health related quality of life, Up to 3 months after completion of neoadjuvant chemotherapy treatment|Questionnaire Memorial Symptom Assessment Scale (MSAS), To evaluate self-reported data in terms of symptom prevalence, characteristics and distress, Up to 3 months after completion of neoadjuvant chemotherapy treatment
Health care costs, Up to 3 months after completion of neoadjuvant chemotherapy treatment
The purpose of this study is to evaluate the effects of an interactive Information and Communication Technologies (ICT) -platform for use in a smartphone or tablet in patients treated with neoadjuvant chemotherapy for breast cancer. The hypothesis is that clinical management will be improved and costs reduced and safe and participatory care promoted, when patients report symptoms in an application which provides self-care advice and instant access to professionals.